SAB Biotherapeutics Income Statement 2020-2025 | SABS

Revenue

$2.239

$23.904

$60.876

$55.238

Cost Of Goods Sold

Gross Profit

$2.239

$23.904

$60.876

$55.238

Research And Development Expenses

$16.515

$36.439

$57.184

$27.909

SG&A Expenses

$23.799

$16.383

$17.086

$6.772

Other Operating Income Or Expenses

Operating Expenses

Operating Income

$-38.075

$-28.918

$-13.393

$20.557

Total Non-Operating Income/Expense

$-4.119

$10.202

$-3.751

$-0.439

Pre-Tax Income

$-42.194

$-18.715

$-17.145

$20.118

Income Taxes

$0.026

Income After Taxes

$-42.194

$-18.741

$-17.145

$20.118

Other Income

Income From Continuous Operations

$-42.194

$-18.741

$-17.145

$20.118

Income From Discontinued Operations

Net Income

$-42.194

$-18.741

$-17.145

$20.118

EBITDA

$-34.33

$-25.626

$-11.74

$21.105

EBIT

$-38.075

$-28.918

$-13.393

$20.557

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-7.64

$-4.31

$-6.30

$7.90

EPS - Earnings Per Share

$-7.64

$-4.31

$-6.30

$7.40